From Julie Lynch, National Committee <[email protected]>
Subject Fwd: Senate: Act now to reduce high drug costs
Date December 22, 2019 3:12 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Big Pharma needs to be held accountable Hello John,

Does Senate Majority Leader Mitch McConnell really care that millions of Medicare beneficiaries are struggling to afford the lifesaving drugs they need? Let's make sure he does! If you haven't yet signed our Emergency Petition to the U.S. Senate, please take a moment to do it right now. [link removed] It could be one of the most important actions you take to help us rein in the power of drug companies to charge seniors whatever they want for the drugs they need. If you have already signed it: Thank you.

Now, please consider making a gift in whatever amount you can afford [link removed] to help boost our crucial work to protect Americans' access to affordable prescription drugs and strengthen Medicare's financing! We couldn't take on the powerful and well-funded drug industry lobbyists without loyal supporters like you.

Sincerely, Julie Lynch
Member Services Manager

 
Begin forwarded message:   [link removed]     SIGN Our Emergency Petition to
the Senate! [link removed]   DearJohn,  Last week, the House of Representatives passed a sweeping and historic bill to lift the burden of crushing prescription drug prices. The "Lower Drug Prices Now Act" (H.R. 3), [link removed] which, among other things, will empower Medicare to negotiate prices directly with drug makers, also delivers a sorely-needed, $2,000 annual cap on out-of-pocket drug costs for Medicare Part D beneficiaries. The bill then leverages the projected $456 billion in savings from lower drug prices to expand Medicare to include dental, vision and hearing coverage — a long-sought goal of the National Committee.
  <em>The fight to lower prescription drug costs now moves to the Senate where we must call on lawmakers to follow the House&#39;s lead!</em> So please <a alt="Click Here to Sign Our Petition" href="[link removed]" name="petition_senate_drug_bill" style="text-decoration: underline; color: #004D96; text-align: left;" title="Click Here to Sign Our Petition" ><strong><u>sign our Emergency Petition to the U.S. Senate,</u></strong></a> and urge them to act immediately to relieve the financial pain of high drug prices inflicted on America&#39;s seniors and their families!
John, as you know, Big Pharma has been steadily raising <a alt="Click Here to Learn More" href="[link removed]" name="petition_senate_drug_bill" style="text-decoration: underline; color: #004D96; text-align: left;" title="Click Here to Learn More" ><strong><u>drug prices</u></strong></a> during the past two decades, in the absence of any government negotiation authority. Meanwhile, the drug industry's profits have soared, as has CEO compensation. The industry spends billions on lobbying and marketing &mdash; more than $6 billion for ads alone in 2018.
 
Skyrocketing drug prices impact the health and financial security of millions older Americans! That's why we need you engaged in this urgent battle to lower soaring drug costs and hold Big Pharma accountable for their callous pricing policies! So please, sign the National Committee's Emergency Petition [link removed] right now! Help us convince the Senate to take meaningful action to restore some fairness to the prescription drug market!
          Sincerely, Max Richtman
President & CEO   [link removed] [link removed] [link removed] Member contributions to the National Committee, a nonprofit 501(c)(4)
organization, are not tax-deductible.
 
Copyright© 2019 by the National Committee
111 K Street, NE, Suite 700 | Washington, DC 20002
www.ncpssm.org [link removed] | 1-800-966-1935
 
View this email in a browser [link removed] | Click here to unsubscribe [link removed]
Privacy Policy [link removed] | Disclosure Statement [link removed] | Click here to donate [link removed]   
Screenshot of the email generated on import

Message Analysis